| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/03/2005 | US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 03/03/2005 | US20050048059 Binding to epitope which contains peptide and carbohydrate on tumor; anticancer agents |
| 03/03/2005 | US20050048058 Antibody against fibroblast growth factor-23 |
| 03/03/2005 | US20050048057 Diagnosis, therapy of cancer, cardiovascular disorders, atherosclerosis, restenosis, osteoporosis, antiinflammatory agents |
| 03/03/2005 | US20050048056 Method for the preparation of molecules having antibody activity |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048054 Lymphocytes; methods |
| 03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/03/2005 | US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits |
| 03/03/2005 | US20050048050 Administering insulin-like growth factor binding protein; antitumor, anticancer agents ; genetic engineered antibody |
| 03/03/2005 | US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide |
| 03/03/2005 | US20050048038 Efficient production of f(ab')2 fragments in mammalian cells |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | DE10337368A1 Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids |
| 03/03/2005 | CA2537263A1 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2536819A1 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp |
| 03/03/2005 | CA2536408A1 Improved antibodies having altered effector function and methods for making the same |
| 03/03/2005 | CA2536359A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 03/03/2005 | CA2536328A1 Method of examining colon cancer and colon adenoma |
| 03/03/2005 | CA2536317A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 03/03/2005 | CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation |
| 03/03/2005 | CA2536062A1 Methods for reducing complexity of a sample using small epitope antibodies |
| 03/03/2005 | CA2535976A1 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 03/03/2005 | CA2535859A1 Endotheliase-2 ligands |
| 03/03/2005 | CA2535804A1 Anti-lewis y anti-idiotypic antibodies and uses thereof |
| 03/03/2005 | CA2535583A1 Method of inducing immune tolerance |
| 03/03/2005 | CA2535510A1 Detecting and profiling molecular complexes |
| 03/03/2005 | CA2535171A1 Tie1-binding ligands |
| 03/03/2005 | CA2531995A1 Methods, kits and antibodies for detecting parathyroid hormone |
| 03/03/2005 | CA2530821A1 Hiv immunogenic complexes |
| 03/03/2005 | CA2529647A1 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2005 | CA2526431A1 Compositions and methods for treatment of severe acute respiratory syndrome (sars) |
| 03/02/2005 | EP1510821A1 Diagnosis and treatment of mycobacterial infections |
| 03/02/2005 | EP1510579A2 Use of heregulin as an epithelial cell growth factor |
| 03/02/2005 | EP1509606A1 Allergen from mugwort pollen |
| 03/02/2005 | EP1509547A1 Antobodies to adipose tissues |
| 03/02/2005 | EP1509543A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 03/02/2005 | EP1509539A2 Novel compositions and methods for cancer |
| 03/02/2005 | EP1509236A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 03/02/2005 | EP1509166A2 Method for improving body weight gain and feed conversion efficiency in animals |
| 03/02/2005 | EP1299327A4 Phosphorylated polypeptides and uses related thereto |
| 03/02/2005 | EP1198475B1 Highly purified cytokine activating factor and methods of use |
| 03/02/2005 | EP1034291B1 Pseudo-type retroviral vectors with modified surface capsid proteins and method for the production thereof for selective gene transfer |
| 03/02/2005 | EP0959896A4 Human thyrotropin receptor compositions and use thereof |
| 03/02/2005 | EP0919617B1 Anti-human mp52 monoclonal antibody |
| 03/02/2005 | EP0907731B1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | EP0797591B1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 03/02/2005 | EP0741868B1 Immunoassays for prostate specific antigen |
| 03/02/2005 | CN1589280A Treatment of micro-organism infection |
| 03/02/2005 | CN1589278A Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 03/02/2005 | CN1589152A Novel human beta 2 integrin alpha subunit |
| 03/02/2005 | CN1191361C Carrot anti-freeze polypeptides |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191275C Antifucoidan polysacchearide antibody |
| 03/02/2005 | CN1191274C Preparation of prawn white spot baculovirus recognizing single chain antibody |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/02/2005 | CN1191075C Composition and method for increasing weight gain and feed efficiency |
| 03/01/2005 | US6861572 Production of proteins in eggs |
| 03/01/2005 | US6861511 Detection and quantification of neu related proteins in the biological fluids of humans |
| 03/01/2005 | US6861510 Immunogenic compositions against gastrin peptides |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861405 Administering to an animal a voltage-gated potassium channel Kv1.3 inhibiting amount of a Kv1.3 inhibitor to induce weight loss, decrease body fat, increase insulin sensitivity, decrease food intake and control appetite |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861242 Reacting glucosidase and phosphotransferase |
| 03/01/2005 | US6861239 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof |
| 03/01/2005 | US6861231 Immunoglobulin for use diagnostic tool in genetic engineering |
| 03/01/2005 | US6861228 Modulating Robo: ligand interactions |
| 03/01/2005 | US6861212 NANBV diagnostics and vaccines |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 02/24/2005 | WO2005017484A2 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 02/24/2005 | WO2005017179A2 Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005017149A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | WO2005017148A1 Binding constructs and methods for use thereof |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017107A2 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | WO2005016979A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | WO2005016970A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/24/2005 | WO2005016969A2 Cd20-binding polypeptide compositions |
| 02/24/2005 | WO2005016968A2 Reducing protein a leaching during protein a affinity chromatography |
| 02/24/2005 | WO2005016967A2 Modified human igf-1r antibodies |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016951A2 Anti-ghrelin fab antibodies |
| 02/24/2005 | WO2005016950A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | WO2005016455A2 Antibodies against factor viii with modified glycosylation in the variable region |
| 02/24/2005 | WO2005016383A1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016381A2 Combination therapy for the treatment and prevention of cancer using epha2, pcdgf, and haah |
| 02/24/2005 | WO2005016379A1 Compositions and methods for manipulating levels antigen-specific antibodies in a mammal |
| 02/24/2005 | WO2005016281A2 Diagnosis and treatment of malignant neoplasms |
| 02/24/2005 | WO2005016266A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | WO2005016263A2 Compositions and methods for treating hyperimmune response in the eye |
| 02/24/2005 | WO2005016236A2 Antibodies that immunospecifically bind to trail receptors |
| 02/24/2005 | WO2005016232A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 02/24/2005 | WO2005016132A2 Diagnostics for sars virus |
| 02/24/2005 | WO2005016127A2 Prion-specific peptide reagents |
| 02/24/2005 | WO2005016111A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 02/24/2005 | WO2004113388A3 Anti alpha - folate - receptor - tetramer antibodies |